Should patients with cirrhosis and variceal hemorrhage receive glucocorticoid therapy?

Hepatology. 2015 May;61(5):1758-60. doi: 10.1002/hep.27762. Epub 2015 Mar 20.

Authors

Richard Moreau¹, Emmanuel Weiss

Affiliation

¹ Inserm, U1149, Centre de Recherche sur l'Inflammation, Paris, France; UMR S 1149, Université Paris Diderot-Paris 7, Faculté de Médecine Bichat, Paris, France; Département Hospitalo-Universitaire UNITY, Service d'Hépatologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France; Laboratoire d'Excellence (Labex) INFLAMEX, PRES Sorbonne Paris Cité, Paris, France.

PMID: 25712004
DOI: 10.1002/hep.27762

No abstract available

Publication types

Comment

MeSH terms

Adrenal Cortex / metabolism*
Critical Illness / mortality*
Esophageal and Gastric Varices / mortality*
Female
Gastrointestinal Hemorrhage / mortality*
Humans
Liver Cirrhosis / mortality*
Male